| Role of microenvironment on the fate of disseminating cancer stem cells V Ingangi, M Minopoli, C Ragone, ML Motti, MV Carriero Frontiers in oncology 9, 82, 2019 | 67 | 2019 |
| Myeloid cells as clinical biomarkers for immune checkpoint blockade E Peranzoni, V Ingangi, E Masetto, L Pinton, I Marigo Frontiers in immunology 11, 552713, 2020 | 57 | 2020 |
| Disabled homolog 2 controls prometastatic activity of tumor-associated macrophages I Marigo, R Trovato, F Hofer, V Ingangi, G Desantis, K Leone, F De Sanctis, ... Cancer Discovery 10 (11), 1758-1773, 2020 | 43 | 2020 |
| Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules L Pinton, S Magri, E Masetto, M Vettore, I Schibuola, V Ingangi, I Marigo, ... Journal of Nanobiotechnology 18, 1-12, 2020 | 38 | 2020 |
| Cyclization of the urokinase receptor-derived ser-arg-ser-arg-tyr peptide generates a potent inhibitor of trans-endothelial migration of monocytes AM Yousif, M Minopoli, K Bifulco, V Ingangi, G Di Carluccio, F Merlino, ... PLoS One 10 (5), e0126172, 2015 | 27 | 2015 |
| Retro-inverso urokinase receptor antagonists for the treatment of metastatic sarcomas MV Carriero, K Bifulco, V Ingangi, S Costantini, G Botti, C Ragone, ... Scientific Reports 7 (1), 1312, 2017 | 23 | 2017 |
| Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells C Ragone, M Minopoli, V Ingangi, G Botti, F Fratangelo, A Pessi, ... Journal of Experimental & Clinical Cancer Research 36, 1-16, 2017 | 22 | 2017 |
| Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence K Bifulco, G Votta, V Ingangi, G Di Carluccio, D Rea, S Losito, N Montuori, ... Oncotarget 5 (12), 4154, 2014 | 20 | 2014 |
| The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells V Ingangi, K Bifulco, AM Yousif, C Ragone, ML Motti, D Rea, M Minopoli, ... Oncotarget 7 (34), 54474, 2016 | 19 | 2016 |
| A macroscopic mathematical model for cell migration assays using a real-time cell analysis E Di Costanzo, V Ingangi, C Angelini, MF Carfora, MV Carriero, R Natalini PLoS One 11 (9), e0162553, 2016 | 17 | 2016 |
| Treatment with a urokinase receptor-derived cyclized peptide improves experimental colitis by preventing monocyte recruitment and macrophage polarization M Genua, V Ingangi, P Fonteyne, A Piontini, AM Yousif, F Merlino, ... Inflammatory Bowel Diseases 22 (10), 2390-2401, 2016 | 16 | 2016 |
| Melanoma and immunotherapy bridge 2015: Naples, Italy. 1–5 December 2015 VGY Nanda, W Peng, P Hwu, MA Davies, G Ciliberto, L Fattore, ... Journal of Translational Medicine 14, 1-27, 2016 | 15 | 2016 |
| Urokinase receptor derived peptides as potent inhibitors of the formyl peptide receptor type 1-triggered cell migration AM Yousif, V Ingangi, F Merlino, D Brancaccio, M Minopoli, R Bellavita, ... European Journal of Medicinal Chemistry 143, 348-360, 2018 | 14 | 2018 |
| Structure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity M Minopoli, A Polo, C Ragone, V Ingangi, G Ciliberto, A Pessi, S Sarno, ... Scientific Reports 9 (1), 12169, 2019 | 11 | 2019 |
| Poly (L-glutamic acid)-co-poly (ethylene glycol) block copolymers for protein conjugation K Maso, A Grigoletto, L Raccagni, M Bellini, I Marigo, V Ingangi, A Suzuki, ... Journal of controlled release 324, 228-237, 2020 | 8 | 2020 |
| Disabled homolog 2 controls prometastatic activity of tumor-associated macrophages. Cancer Discov. 2020; 10: 1758–1773. doi: 10.1158/2159-8290 I Marigo, R Trovato, F Hofer, V Ingangi, G Desantis, K Leone, F De Sanctis, ... CD-20-0036.[Abstract][CrossRef][Google Scholar], 0 | 7 | |
| A macroscopic mathematical model for cell migration assays using a real-time cell analysis ED Costanzo, V Ingangi, C Angelini, MF Carfora, MV Carriero, R Natalini PLOS ONE 11 (9), 1-20, 2016 | 1 | 2016 |
| Improving the Therapeutic Potential of G-CSF through Compact Circular PEGylation Based on Orthogonal Conjugations A Grigoletto, V Marotti, T Tedeschini, B Campara, I Marigo, V Ingangi, ... Biomacromolecules 24 (9), 4229-4239, 2023 | | 2023 |
| Monoclonal antibodies decorated nanoparticles for the treatment of triple negative breast cancer S Breusa, J Delcros, E Thomas, S Zilio, DMH Palomino, V Ingangi, ... SFNano Annual Meeting, 2022 | | 2022 |
| Urokinase receptor antagonists: novel agents for the treatment of melanoma ML Motti, K Bifulco, V Ingangi, M Minopoli, C Ragone, F Fratangelo, ... JOURNAL OF TRANSLATIONAL MEDICINE 14, 2016 | | 2016 |
